Group 1 - The core viewpoint of the articles highlights the performance and market position of Shenzhen New Industry Biomedical Engineering Co., Ltd. in the medical device sector, showcasing its financial results and industry rankings [1][2] - As of August 6, the company's stock closed at 55.7 yuan, with a rolling PE ratio of 23.79 times and a total market capitalization of 43.765 billion yuan [1] - The average PE ratio for the medical device industry is 53.93 times, with a median of 37.81 times, placing the company at the 50th position within the industry [1][2] Group 2 - The company reported a revenue of 1.125 billion yuan for Q1 2025, reflecting a year-on-year increase of 10.12%, and a net profit of 438 million yuan, up 2.65% year-on-year, with a gross profit margin of 68.01% [1] - A total of 48 institutions hold shares in the company, with 48 funds collectively owning 33.4155 million shares valued at 1.895 billion yuan [1] - The company has been recognized with the "National Brand Gold Award" for medical equipment in 2024, achieving the top rank in customer satisfaction metrics among tertiary hospitals [1]
新产业收盘上涨1.64%,滚动市盈率23.79倍,总市值437.65亿元